Correlation Between Lion Biotechnologies and Hermès International

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lion Biotechnologies and Hermès International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lion Biotechnologies and Hermès International into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lion Biotechnologies and Herms International Socit, you can compare the effects of market volatilities on Lion Biotechnologies and Hermès International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lion Biotechnologies with a short position of Hermès International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lion Biotechnologies and Hermès International.

Diversification Opportunities for Lion Biotechnologies and Hermès International

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Lion and Hermès is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Lion Biotechnologies and Herms International Socit in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Herms International Socit and Lion Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lion Biotechnologies are associated (or correlated) with Hermès International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Herms International Socit has no effect on the direction of Lion Biotechnologies i.e., Lion Biotechnologies and Hermès International go up and down completely randomly.

Pair Corralation between Lion Biotechnologies and Hermès International

Assuming the 90 days trading horizon Lion Biotechnologies is expected to generate 3.45 times more return on investment than Hermès International. However, Lion Biotechnologies is 3.45 times more volatile than Herms International Socit. It trades about 0.03 of its potential returns per unit of risk. Herms International Socit is currently generating about 0.05 per unit of risk. If you would invest  595.00  in Lion Biotechnologies on October 5, 2024 and sell it today you would earn a total of  107.00  from holding Lion Biotechnologies or generate 17.98% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy99.8%
ValuesDaily Returns

Lion Biotechnologies  vs.  Herms International Socit

 Performance 
       Timeline  
Lion Biotechnologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lion Biotechnologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Herms International Socit 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Herms International Socit are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Hermès International may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Lion Biotechnologies and Hermès International Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lion Biotechnologies and Hermès International

The main advantage of trading using opposite Lion Biotechnologies and Hermès International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lion Biotechnologies position performs unexpectedly, Hermès International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hermès International will offset losses from the drop in Hermès International's long position.
The idea behind Lion Biotechnologies and Herms International Socit pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance